Search

Search Results

• 

  Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

  Gary E. Raskob

  16-05-2024

  Published: 16 May 2024

  335

  PDF: 156
• 

  Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

  Agnes Y.Y. Lee

  29-02-2024

  Published: 29 February 2024

  1258

  PDF: 212
• 

  Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study

  Cristina Legnani, Michela Cini, Sophie Testa, Alberto Tosetto, Claudia Dellanoce, Stefania Bellesso, Giuseppe Carli, Ilaria Nichele, Laura Lissandrini, Serena Zorzi, Emilia Antonucci, Gualtiero Palareti

  01-12-2022

  Published: 1 December 2022

  1284

  PDF: 256
• 

  Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

  Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

  27-06-2023

  Published: 27 June 2023

  1069

  PDF: 242

  Supplementary File: 117
• 

  Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

  Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

  22-03-2022

  Published: 22 March 2022

  861

  PDF: 303

  APPENDIX: 59
• 

  The new era of anticoagulation: factor XI and XII inhibitors

  Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol

  07-06-2023

  Published: 7 June 2023

  1813

  PDF: 782
• 

  Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia

  Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga

  28-06-2023

  Published: 28 June 2023

  435

  PDF: 152
• 

  Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques?

  Marcello Baroni, Paolo Ferraresi, Nicole Ziliotto, Daria Bortolotti, Pierfilippo Acciarri, Nicola Martinelli, Giovanna Marchetti, Matteo Coen, Francesco Bernardi

  17-10-2022

  Published: 17 October 2022

  2006

  PDF: 189
• 

  Location of metastasis and complications in patients with venous thromboembolism and cancer: systematic review

  Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

  16-05-2024

  Published: 16 May 2024

  304

  PDF: 107
• 

  Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

  Robert Parambi, Nicole Ziliotto, Francesco Bernardi , Marcello Baroni , Richard W Browne , Dejan Jakimovski, Bianca Weinstock-Guttman, Robert Zivadinov, Murali Ramanathan

  17-10-2022

  Published: 17 October 2022

  2153

  PDF: 219

  Supplementary Files: 48
• 

  Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

  Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

  03-08-2023

  Published: 3 August 2023

  1191

  PDF: 409
• 

  Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

  Marco P. Donadini, Walter Ageno

  15-04-2022

  Published: 15 April 2022

  1920

  PDF: 490

• Distal deep vein thrombosis: is there a way out of this dark forest?

  Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

  04-09-2024

  Published: 4 September 2024

  431

  PDF: 134
• 

  Endothelial cell dysfunction in cancer: a not-so-innocent bystander

  Betül Ünlü, Neha Joshi, Jamie M. O'Sullivan

  16-05-2024

  Published: 16 May 2024

  939

  PDF: 142